Anthropic IPO Countdown: How I Would Position Before ANT Starts Trading?
Anthropic’s IPO is approaching the moment when all the hype gets tested by an actual market price.
The proposed offering is enormous: 825 million Class A shares at $70–$78, implying gross public-offering proceeds of roughly $57.75 billion to $64.35 billion. Of those shares, 801.35 million are being issued by Anthropic and 23.65 million are being sold by existing shareholders.
Bloomberg has reported that demand is around six times the shares available.
That sounds incredibly bullish, but I would not automatically interpret six-times oversubscription as six-times conviction.
For me, the important information comes next.
The final IPO price matters more than the headline
If Anthropic prices at the top of the current $70–$78 range, that would tell me investors are willing to pay up to secure an allocation.
If the company prices above $78, that would be an even stronger signal that institutional demand remained aggressive throughout the book-building process.
But I would still distinguish between demand and valuation.
A highly oversubscribed IPO can produce a strong debut, but it can also create a situation where investors are competing for a limited float and then reassessing the valuation once the stock begins trading freely.
That is why I would pay close attention to the final offer price relative to the original range, rather than simply whether the IPO was oversubscribed.
Allocation may reveal more than oversubscription
This is the part I find particularly interesting.
If the reported six-times demand is real, Anthropic cannot satisfy everyone.
So I would want to know who actually receives the shares and how much they receive.
If large institutional investors receive meaningful allocations despite enormous demand, that could suggest the book is supported by investors willing to hold through the volatility rather than simply traders looking for a first-day pop.
On the other hand, if allocations are extremely small across a very large investor base, it would tell me that the headline demand may be much less useful as a measure of how much capital investors are actually prepared to commit.
In other words, the quality of the demand matters more than the quantity of the orders.
The $26 billion private placement is a different signal
Anthropic also has a separate $26 billion Class N private placement involving major technology and semiconductor companies including Nvidia, Microsoft, Alphabet/Google, AMD, Broadcom, Micron and TSMC Partners. $NVIDIA(NVDA)$ $Microsoft(MSFT)$ $Alphabet(GOOG)$
I would not combine that $26 billion with the public IPO when judging public-market demand.
The private placement is contingent on the IPO and is being purchased by strategic investors at the IPO price. These investors have commercial interests in the AI ecosystem as well as financial exposure.
That makes the placement important, but it is not equivalent to 26 billion dollars of additional public-market demand.
What I find more interesting is what their participation says about the AI supply chain.
Companies responsible for GPUs, custom accelerators, memory, manufacturing, cloud infrastructure and AI platforms are collectively putting capital behind Anthropic.
That creates a powerful ecosystem around Claude — but it also means Anthropic’s future economics will depend heavily on the cost of compute.
The biggest risk is not whether Claude is popular
I think the market already has enough evidence that frontier AI demand is real.
The harder question is how profitable that demand will become.
Anthropic is growing rapidly, but frontier AI requires enormous computing resources. Investors therefore need to think about revenue growth together with inference costs, training costs, infrastructure commitments and eventual operating margins.
That is why I would be careful about extrapolating today’s revenue growth indefinitely.
At a valuation approaching the trillion-dollar level or potentially higher if the IPO prices above its initial range, the market will eventually demand more than impressive user growth.
It will demand evidence that Anthropic can turn AI demand into durable free cash flow.
How I would position myself
I would not treat the IPO as an automatic buy simply because it is oversubscribed.
My preferred approach would be to watch the final IPO price, actual allocation, first-day trading behaviour and early post-listing financial performance as four separate signals.
If the IPO prices above the range and still trades strongly without an extreme first-day spike, I would see that as healthier demand than a spectacular opening followed by heavy profit-taking.
I would also compare Anthropic’s market valuation with the valuations of the companies supplying its infrastructure.
If ANT receives a huge premium while Nvidia, TSMC, Microsoft or Alphabet are trading at much lower expectations relative to their existing earnings and cash flows, I would not automatically chase the new listing.
The IPO gives investors something the private market has never provided at this scale: a daily market price for one of the leading frontier-AI companies.
That makes Anthropic’s debut important beyond Anthropic itself.
My view
I am interested in ANT, but I would rather see the price discovery than blindly chase the IPO.
The strongest signal would be a final price that reflects genuine institutional demand, healthy allocations and sustained trading after the initial excitement fades.
For me, the first few weeks will be more informative than the first few hours.
If Anthropic can command a premium valuation while continuing to demonstrate strong revenue growth and improving economics, it could become one of the most important public-market benchmarks for the AI industry.
But if the IPO’s valuation gets ahead of the underlying economics, the same enthusiasm that creates a spectacular debut could eventually become the source of the downside.
I would rather miss the first 10% of an IPO rally than pay an AI premium that requires everything to go perfectly. $Anthropic(ANT)$
Comments